Skip to main content
. Author manuscript; available in PMC: 2013 May 3.
Published in final edited form as: Clin Gastroenterol Hepatol. 2012 May 18;10(10):1143–1151. doi: 10.1016/j.cgh.2012.05.003

Figure 5. Three-Way Sensitivity Analysis on Disutility of 5-ASA Maintenance Medication, Disutility of Stool Testing, and Utility of Moderate Disease Flare.

Figure 5

White region indicates values for which INFLAM is the optimal strategy. Light gray region indicates values for which SYMPT is the optimal strategy. Dark gray region indicates values for which CONT is the optimal strategy.